Literature DB >> 10804138

The impact of foodborne calicivirus disease: the Minnesota experience.

V C Deneen1, J M Hunt, C R Paule, R I James, R G Johnson, M J Raymond, C W Hedberg.   

Abstract

The first outbreaks of Norwalk virus gastroenteritis in Minnesota were confirmed in 1982. Since then, Norwalk-like caliciviruses have been recognized to be the most common cause of foodborne disease outbreaks, accounting for 41% of all confirmed foodborne outbreaks in Minnesota from 1981-1998. Although laboratory confirmation of caliciviruses in stool samples was not attempted in most of these outbreaks, all conformed to epidemiologic criteria for defining outbreaks of Norwalk virus. Since 1996, the availability of polymerase chain reaction testing at the Minnesota Department of Health has allowed for the confirmation of calicivirus infection among patients involved in epidemiologically defined outbreaks of viral gastroenteritis. Results have confirmed the usefulness of characterizing foodborne disease outbreaks by epidemiologic criteria and also confirmed the importance of human caliciviruses as the leading cause of foodborne disease outbreaks in Minnesota.

Entities:  

Mesh:

Year:  2000        PMID: 10804138     DOI: 10.1086/315583

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Norwalk-like virus sequences in mineral waters: one-year monitoring of three brands.

Authors:  Christian Beuret; Dorothe Kohler; Andreas Baumgartner; Thomas M Lüthi
Journal:  Appl Environ Microbiol       Date:  2002-04       Impact factor: 4.792

2.  The use of clinical profiles in the investigation of foodborne outbreaks in restaurants: United States, 1982-1997.

Authors:  C W Hedberg; K L Palazzi-Churas; V J Radke; C A Selman; R V Tauxe
Journal:  Epidemiol Infect       Date:  2007-03-05       Impact factor: 2.451

3.  Sensitive detection of RNA viruses associated with gastroenteritis by a hanging-drop single-tube nested reverse transcription-PCR method.

Authors:  Rodney Mark Ratcliff; James Christopher Doherty; Geoffrey David Higgins
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

4.  Development of a microsphere-based serologic multiplexed fluorescent immunoassay and a reverse transcriptase PCR assay to detect murine norovirus 1 infection in mice.

Authors:  Charlie C Hsu; Christiane E Wobus; Earl K Steffen; Lela K Riley; Robert S Livingston
Journal:  Clin Diagn Lab Immunol       Date:  2005-10

5.  Enhanced surveillance of norovirus outbreaks of gastroenteritis in Georgia.

Authors:  Marc-Alain Widdowson; Sandra N Bulens; R Suzanne Beard; Kimberley M Lane; Stephen S Monroe; Susan Lance; Joseph S Bresee; Roger I Glass
Journal:  Public Health Rep       Date:  2011 Mar-Apr       Impact factor: 2.792

Review 6.  Plant-based oral vaccines: results of human trials.

Authors:  C O Tacket
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

7.  Survival of F-specific RNA coliphage, feline calicivirus, and Escherichia coli in water: a comparative study.

Authors:  Paul B Allwood; Yashpal S Malik; Craig W Hedberg; Sagar M Goyal
Journal:  Appl Environ Microbiol       Date:  2003-09       Impact factor: 4.792

8.  Caliciviruses and foodborne gastroenteritis, Chile.

Authors:  Roberto Vidal; Veronica Solari; Nora Mamani; Xi Jiang; Jimena Vollaire; Patricia Roessler; Valeria Prado; David O Matson; Miguel L O'Ryan
Journal:  Emerg Infect Dis       Date:  2005-07       Impact factor: 6.883

9.  Norovirus and foodborne disease, United States, 1991-2000.

Authors:  Marc-Alain Widdowson; Alana Sulka; Sandra N Bulens; R Suzanne Beard; Sandra S Chaves; Roberta Hammond; Ellen D P Salehi; Ellen Swanson; Jessica Totaro; Ray Woron; Paul S Mead; Joseph S Bresee; Stephan S Monroe; Roger I Glass
Journal:  Emerg Infect Dis       Date:  2005-01       Impact factor: 6.883

Review 10.  Hygienic hand antiseptics: should they not have activity and label claims against viruses?

Authors:  Syed A Sattar; V Susan Springthorpe; Jason Tetro; Robert Vashon; Bruce Keswick
Journal:  Am J Infect Control       Date:  2002-10       Impact factor: 2.918

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.